Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPravinwan Thungthongen_US
dc.contributor.authorSupat Chamnanchanunten_US
dc.contributor.authorTawatchai Suwanbanen_US
dc.contributor.authorChajchawan Nakhakesen_US
dc.contributor.authorKunapa Iam-Arunthaien_US
dc.contributor.otherRajavithi Hospitalen_US
dc.contributor.otherMahidol Universityen_US
dc.identifier.citationAsian Biomedicine. Vol.9, No.5 (2015), 697-700en_US
dc.description.abstractBackground: A Janus kinase 2 (JAK2) mutation polycythemia vera (PV) is a common manifestation of stem cell disorder. However, available data on the clinical and treatment response of JAK2-negative PV patients are limited. Objectives: We report the case and clinical course of a patient with PV and left hemiparesis who was JAK2V617- negative. Methods: We conducted a literature review and compared our patient with previously published reports of JAK2-negative patients with PV. Results: Our patient presented with hemiparesis without a previous history of hematological disease. He was diagnosed with PV based on the British Committee for Standards in Haematology guidelines 2007. He underwent only phlebotomy with subsequent improvement of his neurological condition. He was discharged with therapeutic phlebotomy for one and a half months. Conclusions: Although this rare condition required complex diagnostic criteria, the patient achieved good clinical outcome with therapeutic phlebotomy alone.en_US
dc.rightsMahidol Universityen_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleJanus kinase 2 negative polycythemia veraen_US
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.